-
Concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): final and exploratory analyses of a randomised, open-label, phase 3 trial
van den Bent, M. J., Ghisai, S. A., Wick, W., Sanson, M., Brandes, A. A., Clement, P. M., Erridge, S. C., Vogelbaum, M. A., Nowak, A. K., Baurain, J.-F., Mason, W. P., Wheeler, H., Tabouret, E., Gill, S., Griffin, M., Taal, W., Rudà, R., Weller, M., McBain, C. & Reijneveld, J. C. & 21 others, , 1 Jan 2026, In: lancet oncology. 27, 1, p. 45-56 12 p.Research output: Contribution to Journal › Article › Academic › peer-review
-
Transcriptomic analysis of EGFR co-expression and activation in glioblastoma reveals associations with its ligands
Ghisai, S. A., Barin, N., van Hijfte, L., Verhagen, K., de Wit, M., van den Bent, M. J., Hoogstrate, Y. & French, P. J., 1 Jan 2025, In: Neuro-Oncology Advances. 7, 1, vdae229.Research output: Contribution to Journal › Article › Academic › peer-review
- All publications
